MSB 1.01% 98.5¢ mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-364

  1. 1,961 Posts.
    lightbulb Created with Sketch. 135
    Can we assume on this basis that at 60% readout we will have overwhelming efficacy ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.